Researchers will determine if a promising new drug used to
treat dogs with hemangiosarcoma would benefit dogs with other incurable cancers.
Not exact matches
Researchers at the University of Pennsylvania School of Veterinary Medicine
treated dogs with a commercially available Coriolus versicolor product and found the longest reported survival time for
dogs with hemangiosarcoma.
Finding a new approach to
treat canine
hemangiosarcoma is a vital step in improving survival rates in
dogs with this aggressive cancer.
The two other
dogs (one
treated with COP chemotherapy and 1
treated with prednisone alone) were euthanized at 722 and 958 days respectively; as noted above, the first
dog had
hemangiosarcoma and the second
dog was euthanized due to «declining health.»